-
US Shares
18 Oct 2024 21:18 GMT
Business World, Ireland's leading source for Financial and Business news brings you the latest market share prices from the US as they occur.
Name
Latest
Change
Previous
Day Hi
Day Lo
Details
21ST CENTRY FOX A CM
24.12
-0.1
24.22
24.59
24.09
More
…
-
Dr Reddy’s Laboratories shares fall 2% on potential antitrust lawsuit in US
01 Mar 2024 09:28 GMT
Shares of pharma firm Dr Reddy’ … .35 on BSE.
Total 6051 shares of the firm changed hands … ;s, acting in connection with Celgene Corporation, Bristol-Myers Squibb Co …
-
Natco Pharma shares falls 4% on anti-trust lawsuit in US
08 Sep 2023 08:53 GMT
Leading oncology drug maker Natco Pharma’s stock plummeted as much as 4 per cent to hit an intraday low of Rs 878 per share. The fall in the stock came on the back of a lawsuit filed against the company and its partners in the United States.
In an …
-
Shilpa Medicare shares jump 12% today amid heavy volumes; here's why
11 Apr 2023 05:38 GMT
… average volume of 70,000 shares. Turnover on the counter stood … listed drug (RLD) OTEZLA of Celgene. According to IQVIA MAT Q4 … Research Analyst at Anand Rathi Shares and Stock Brokers.
" … Ports, Ambuja Cements: Adani group shares where MFs cut stakes in …
-
A top-5% fund manager shares 4 reasons why he's getting optimistic about the economy after hiding nearly half of his assets in cash last summer — and details 6 of his favorite stocks to buy now
22 Feb 2023 13:20 GMT
… he acquired after it bought Celgene, a smaller firm with a … of cash, he noted that shares haven't gone anywhere … wasn't growing quickly. Shares exploded higher in recent years …
-
Natco Pharma introduces Celgene’s cancer drug generic Pomalyst in Australia
10 Nov 2022 04:45 GMT
… is a registered trademark of Celgene/BMS, had $35.6 … data, it said.
Natco Pharma shares closed 1.28% lower at …
-
GSK's blood cancer drug fails main goal of trial, shares fall
07 Nov 2022 07:39 GMT
… health authorities, other trials continuing
Shares fall 3%
Nov 7 (Reuters … and vaccine business and its shares fell 3% after its statement … dexamethasone. Pomalidomide was developed by Celgene, now part of Bristol-Myers …
-
Vasculitis Treatment Market 2027 – Status and Development, Average Product Price and Market Shares of Key Players
02 Nov 2022 09:28 GMT
Increasing health literacy has positively aided the Vasculitis Treatment Market
HYDERABAD, TELANGANA, INDIA, November 2, 2022 /EINPresswire.com/ -- Vasculitis Treatment Market size is estimated to reach $621 million by 2027. Furthermore, it is …
-
Global Pancreatic Cancer Treatment Market Research Report to 2027 - Players Include AstraZeneca, Celgene, Clovis Oncology, Eli Lilly & Company and Hetero Healthcare - ResearchAndMarkets.com
11 Oct 2022 17:30 GMT
… an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals … Plc.
Bristol-Myers Squibb Company
Celgene Corporation
Clovis Oncology
Eli Lilly …
-
Hansen's Disease Therapeutics Market Shares SWOT Analysis, Key Development Strategies And Forecasts Till 2028 Novartis, Celgene
16 Aug 2022 22:22 GMT
(MENAFN- Ameliorate Digital Consultancy)
Global Hansen's Disease Therapeutics Size, Status and Outlook 2022 – 2028
The Hansen's Disease Therapeutics Market report is a look of first-hand information, qualitative and quantitative assessment by …
About
© 1995-2025